Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Tumor-Pulsed Dendritic Cells Used as a Tumor Vaccine

This study has been terminated.
Sponsor:
Collaborator:
University of Michigan
Information provided by:
University of Michigan Cancer Center
ClinicalTrials.gov Identifier:
NCT00176761
First received: September 9, 2005
Last updated: September 6, 2006
Last verified: September 2006
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: May 2006
  Estimated Primary Completion Date: No date given